The near-term stock performance may however remain range bound given a high valuation with FY24 expected price-book multiple (P/B) at around seven before capital infusion
Capital infusion plan crucial for Bajaj Finance to be one up on rivals
Date:
The near-term stock performance may however remain range bound given a high valuation with FY24 expected price-book multiple (P/B) at around seven before capital infusion
Popular
© USA Intervierwer. All Rights Reserved.